Dehydroepiandrosterone Sulfate (DHEA-S)
Dehydroepiandrosterone sulfate (DHEA-S) is a steroid hormone that is produced from the precursor cholesterol in the adrenal cortex. From 7 years of age through adult, an increase in DHEA-S levels is observed which then begins to fall gradually after the age of 30. Elevated levels of DHEA-S concentrations are of clinical importance. The androgenic activity of DHEA-S is very weak, although, it can be metabolized into very active androgens like androstenedione or testosterone. These can be indirect causes for hirsutism and virilism. DHEA-S is strongly bound to albumin; only a small portion is non-protein bound, and none appears to be bound to sex hormone-binding globulin (SHBG). The determination of elevated DHEA-S values is an important aid in the diagnosis of hirsutism and virilism, and together with testosterone this represents the screening mechanism of choice to check androgen levels. Diagnostically this test is a rule-out method for androgen-producing tumors. In addition to a differential diagnosis of hirsutism and virilism, further indications for this parameter are all forms of androgenization, hyperprolactinemia, and polycystic ovarian syndrome. As DHEA-S decreases with age this test is very useful in the clinical picture because approximately 80% of women with hirsutism exhibit elevated androgen levels. Decreased levels can be seen and are related to adrenal insufficiency. DHEA-S is often assayed in conjunction with free testosterone as an initial screen for hyperandrogenism in hirsutism. At least one of these two hormones is likely to be elevated in the great majority of cases – reportedly over 80 percent of the time. Sometimes DHEA-S is the only hormone circulating at a level above normal, and is apparently more likely to be elevated during the early stages of hirsutism than most other androgens.
- Aid in investigations of abnormal hair growth (hirsutism) and balding (alopecia) in women
- Hormone therapy monitoring
- Aids in diagnosis of hirsutism, virilism, and hyperandrogenism
- Helpful in excluding adrenal tumors
- Excellent indicator of adrenal cortex androgen production
- Assessment of adrenarche and delayed puberty
Increase in:
- Elevated DHEA-S levels indicate increased adrenal androgen production
- Virilizing adrenal neoplasm
- Female hirsutism (usually adrenal cause)
- In congenital adrenal hyperplasias
Decreased in:
- Adrenal insufficiency
- Decreased with age
| Age | µg/dL | |
| Male | Female | |
| 0–6 days | 108–607 | 108–607 |
| 7–30 days | 32–431 | 32–431 |
| 1–5 months | 3–124 | 3–124 |
| 6–35 months | 0–33 | 0–29 |
| 3–6 years | 0–44 | 0–47 |
| 7–9 years | 5–115 | 5–94 |
| 10–14 years | 22–332 | 22–255 |
| 15–19 years | 88–483 | 63–373 |
| 20–29 years | 280–640 | 65–380 |
| 30–39 years | 120–520 | 45–270 |
| 40–49 years | 95–530 | 32–240 |
| 50–59 years | 70–310 | 26–200 |
| 60–69 years | 42–290 | 13–130 |
| 70 years and older | 28–175 | 10–90 |
| Tanner Stage I | 7–209 | 7–126 |
| Tanner Stage II | 28–260 | 13–241 |
| Tanner Stage III | 39–390 | 32–446 |
| Tanner Stage IV & V | 81–488 | 65–371 |
Electrochemiluminescence immunoassay.
Serum (SST), or plasma.
Stability
- Ambient: 7 days
- Refrigerated: 7 days
- Frozen: 6 months
- Fertil Steril. 2002 Apr;77 Suppl 4:S3-5. [PMID: 12007895]
- Endocr Rev. 1984 Fall;5(4):498-513. [PMID: 6094172]
- Fertil Steril. 2002 Apr;77 Suppl 4:S19-25. [PMID: 12007898]
- J Endocrinol Invest. 1981 Apr-Jun;4(2):197-202. [PMID: 6268694]
- J Endocrinol Invest. 2005;28(3 Suppl):85-93. [PMID: 16042365]
- Alan Wu. Tietz Clinical Guide to Laboratory Tests, Fourth Edition. Saunders; 4 edition (June 13, 2006). ISBN-10: 0721679757